|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29,000.00 KRW | +6.42% |
|
-1.19% | +21.85% |
| 07-08 | Seegene Launches Global Million Clinical Study to Shape New Disease-Specific Testing Standards | CI |
| 05-21 | Seegene Launches Allplex MDRO Assay Under IVDR | CI |
| Market Cap | 1,321B 880M 770M 710M 656M 1.24B 83.91B 1.26B 8.48B 3.33B 41.34B 3.3B 3.23B 142B | P/E 2026 * |
16.4x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 1,321B 880M 770M 710M 656M 1.24B 83.91B 1.26B 8.48B 3.33B 41.34B 3.3B 3.23B 142B | EV / Sales 2026 * |
2.49x | EV / Sales 2027 * | 2.19x |
| Free-Float |
59.55% | Yield 2026 * |
3.79% | Yield 2027 * | 4.1% |
| 1 day | +6.42% | ||
| 1 week | -1.19% | ||
| Current month | -2.36% | ||
| 1 month | +4.50% | ||
| 3 months | +21.34% | ||
| 6 months | +20.83% | ||
| Current year | +21.85% |
| 1 week | 26,850 |  | 30,500 |
| 1 month | 26,350 | | 31,450 |
| Current year | 21,700 | | 32,500 |
| 1 year | 21,700 | | 33,050 |
| 3 years | 19,040 | | 36,650 |
| 5 years | 19,040 | | 90,800 |
| 10 years | 7,225 | | 161,100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jong-Yoon Cheon
CEO | Chief Executive Officer | 69 | 2010-09-16 |
Jung-Yong Kim
DFI | Director of Finance/CFO | 60 | - |
Dae-Hoon Lee
PSD | President | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jong-Yoon Cheon
BRD | Director/Board Member | 69 | 2011-06-30 |
Kyung-Jun Cheon
CHM | Chairman | 79 | - |
Jin-Soo Choi
BRD | Director/Board Member | 74 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-05-29 | Sell | Executive/Senior Manager | 191 | 0.0004% | ||
| 24-05-29 | Sell | Executive/Senior Manager | 4,201 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.42% | -1.19% | -8.81% | +49.25% | 880M | |
| -3.93% | -0.19% | +107.01% | +125.98% | 4.55B | |
| -3.39% | -0.61% | +74.34% | +222.02% | 3.37B | |
| +4.20% | -1.15% | -26.39% | -40.09% | 2.05B | |
| -3.20% | -1.86% | +119.17% | -51.88% | 1.89B | |
| -2.06% | -2.33% | +38.20% | +193.61% | 1.47B | |
| +2.01% | +0.83% | +110.73% | -50.12% | 898M | |
| +1.63% | -3.18% | -36.02% | -18.37% | 483M | |
| +7.05% | +1.07% | -2.52% | - | 487M | |
| +13.46% | 0.00% | - | - | 195M | |
| Average | +2.22% | -0.39% | +41.75% | +53.80% | 1.63B | |
| Weighted average by Cap. | -0.95% | -0.61% | +64.53% | +90.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 531B 354M 309M 285M 263M 500M 33.72B 508M 3.41B 1.34B 16.61B 1.33B 1.3B 57.1B | 603B 402M 351M 324M 299M 568M 38.32B 578M 3.87B 1.52B 18.88B 1.51B 1.48B 64.89B |
| Net income | 92.2B 61.4M 53.71M 49.54M 45.75M 86.82M 5.86B 88.28M 592M 232M 2.88B 231M 226M 9.92B | 108B 72.12M 63.09M 58.19M 53.74M 102M 6.88B 104M 695M 273M 3.39B 271M 265M 11.65B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | ₩29,000.00 | +6.42% | 230,663 |
| 26-07-09 | ₩27,250.00 | -3.54% | 310,249 |
| 26-07-08 | ₩28,250.00 | -3.58% | 246,042 |
| 26-07-07 | ₩29,300.00 | +0.86% | 235,033 |
| 26-07-06 | ₩29,050.00 | -1.02% | 212,640 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A096530 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
